Protagonist Therapeutics Inc (PTGX)
SG&A Expense Growth
-4.74%
Quarterly · Period ending:
PTGX SG&A Expense Growth
Latest reported-4.74%period ending
Latest reported-4.74%period ending
PTGX Quarterly SG&A Growth (QoQ) (0.00% → -4.74%)
Latest values, visible window
High-resolution chart · PNG
PTGX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -4.7375% | |
| 16.1186% | |
| 2.7314% | |
| 5.4876% | |
| -10.1125% | |
| 31.0922% | |
| -11.8527% | |
| 7.6059% | |
| -36.6868% | |
| 85.1714% | |
| 5.0901% | |
| -16.4631% | |
| 6.5892% | |
| 29.7497% | |
| -3.898% | |
| 0.7739% | |
| -29.2708% | |
| 50.3183% | |
| -11.2321% | |
| 8.0566% | |
| 12.5733% | |
| 19.4433% | |
| 2.1059% | |
| 17.0936% | |
| -8.7194% | |
| 11.4195% | |
| 2.2914% | |
| 3.9348% | |
| 2.6302% | |
| 7.023% | |
| 4.6415% | |
| 5.7583% | |
| -12.7403% | |
| 18.5933% | |
| 18.4342% | |
| -16.9974% | |
| 4.4467% | |
| 16.2005% | |
| 63.2213% | |
| 13.0466% | |
| -1.4134% | |
| 75.1238% | |
| -6.3731% | |
| 9.7964% | |
| 55.336% | |
| 0% |